Lophos Holdings Inc.
Lophos Holdings Inc.
Lophos Holdings Inc. pertains to the cultivation and research of Lophophora williamsii (“peyote cactus”). Additionally, in the long-term, the Company is engaged in the research and development of compounds derived from peyote cactus. The company’s wholly-owned subsidiary, Lophos Pharmaceuticals Corp., is a biosciences company that specializes in peyote cactus cultivation, research, and sale. It is also licensed to possess, produce, sell/provide, send, transport and deliver the controlled substances covered by its Controlled Substances Dealers License (CSDL), namely mescaline, psilocin and psilocybin.
Lophos Holdings Inc. (MESC)
SEDAR Information
Company Info
Capitalization
News Releases
Director Departure
Bulletins
2024-0908 - Suspensions - FUTR, MESC, MMAX, STX
le 6 septembre/September 2024
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.
